Advances in endoscopic sleeve gastroplasty for the treatment of obesity and metabolic disease

VernacularTitle:内镜下袖状胃成形术治疗肥胖与代谢病的研究进展
Author: Shiliang DONG ¹ ; Fuqing ZHOU ; Wenhui CHEN ; Cunchuan WANG ; Zhiyong DONG
Author Information

1. 暨南大学医学院第一附属医院胃肠外科/减重中心，广州　510630
Keywords: Obesity; Bariatric surgery; Endoscopic sleeve gastroplasty; Laparoscopic sleeve gastroplasty
From: Chinese Journal of Gastrointestinal Surgery 2023;26(8):803-806
CountryChina
Language:Chinese
Abstract: Obesity poses a serious threat to human health, and although bariatric surgery has been proven effective treatment for morbidly obese patients, its surgical risks and high medical costs limit its clinical application and popularity. Endoscopic sleeve gastroplasty (ESG), as a relatively new endoscopic surgery technique for weight loss, has satisfactory weight loss effects compared to laparoscopic sleeve gastrectomy and lifestyle interventions, while preserving the normal structure of the stomach. Its weight loss effects and safety have been validated in multicenter studies abroad. Although, ESG has not yet been widely performed in China, with the gradual maturity of this technique, its prospects are worth attention in the field of weight loss. In the future, large-scale, long-term, multi-center studies are urgently needed in China to clarify the long-term effects, remission of comorbidities, and occurrence of complications of ESG surgery in obese and metabolic disease patients.